Skip to main content
. 2022 Oct 26;12:1015235. doi: 10.3389/fonc.2022.1015235

Figure 4.

Figure 4

Clinical application of the risk model. (A) Correlation between the risk model and the clinicopathological characteristics of GC patients. (B, C) Univariate analysis and multivariate analysis were conducted to confirm the independent prognosis function of the model. (D, E) ROC, and DCA curves were performed to confirm the superiority of the risk score in clinical application. (F) The nomogram was plotted to obtain the predicting survival time of GC patients. (G) A calibration curve was applied to assess the accuracy of the model in predicting patients’ survival time. (H) The AUC value of the nomogram. *p < 0.05, and ***p < 0.001.